{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:13:20Z","timestamp":1770455600082,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s12265-020-10041-4","type":"journal-article","created":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T23:07:47Z","timestamp":1592521667000},"page":"290-298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Left-Ventricular Function After 3\u00a0Months of Sacubitril-Valsartan in Acute Decompensated Heart Failure"],"prefix":"10.1007","volume":"14","author":[{"given":"Dino","family":"Miri\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darija","family":"Bakovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davor","family":"Eterovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomislav","family":"Sori\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"\u010capkun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivica","family":"Vukovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darko","family":"Duplan\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9935-8904","authenticated-orcid":false,"given":"Ana","family":"Barac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"issue":"27","key":"10041_CR1","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski, P., Voors, A. V., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., Gonz\u00e1lez-Juanatey, J. R., Harjola, V. P., Jankowska, E. A., Jessup, M., Linde, C., Nihoyannopoulos, P., Parissis, J. T., Pieske, B., Riley, J. P., Rosano, G. M. C., Ruilope, L. M., Ruschitzka, F., Rutten, F. H., van der Meer, P., & ESC Scientific Document Group. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, 37(27), 2129\u20132200.","journal-title":"European Heart Journal"},{"key":"10041_CR2","unstructured":"National center for health statistics. (2019). National health and nutrition examination survey (NHANES) public use data files. Centersfor disease control and prevention website. https:\/\/www.cdc.gov\/nchs\/nhanes\/. Accessed 1 April 2019."},{"issue":"1","key":"10041_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.amjcard.2018.03.011","volume":"122","author":"MC Caughey","year":"2018","unstructured":"Caughey, M. C., Sueta, C. A., Stearns, S. C., Shah, A. M., Rosamond, W. D., & Chang, P. P. (2018). Reccurent acute decompensated heart failure admissions for patients with reduced versus preserved ejection fraction (from the atherosclerosis risk in communities studies). The American Journal of Cardiology, 122(1), 108\u2013114.","journal-title":"The American Journal of Cardiology"},{"issue":"1","key":"10041_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/01.CIR.89.1.68","volume":"89","author":"M St John Sutton","year":"1994","unstructured":"St John Sutton, M., Pfeffer, M. A., Plappert, T., Rouleau, J. L., Moy\u00e9, L. A., Dagenais, G. R., Lamas, G. A., Klein, M., Sussex, B., & Goldman, S. (1994). Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protecitve effects of captopril. Circulation, 89(1), 68\u201375.","journal-title":"Circulation"},{"issue":"20","key":"10041_CR5","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1161\/01.CIR.0000070420.51787.A8","volume":"107","author":"M St John Sutton","year":"2013","unstructured":"St John Sutton, M., Lee, D., Rouleau, J. L., Goldman, S., Plappert, T., Braunwald, E., & Pfeffer, M. A. (2013). Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circulation, 107(20), 2577\u20132582.","journal-title":"Circulation"},{"key":"10041_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/01.CIR.86.2.431","volume":"86","author":"MA Konstam","year":"1992","unstructured":"Konstam, M. A., Rousseau, M. F., Kronenberg, M. W., Udelson, J. E., Melin, J., Stewart, D., et al. (1992). Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. Circulation, 86, 431\u2013438.","journal-title":"Circulation"},{"key":"10041_CR7","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0735-1097(02)02063-6","volume":"40","author":"M Wong","year":"2002","unstructured":"Wong, M., Staszewsky, L., Latini, R., Barlera, S., Volpi, A., Chiang, Y. T., et al. (2002). Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study. Journal of the American College of Cardiology, 40, 970\u2013975.","journal-title":"Journal of the American College of Cardiology"},{"key":"10041_CR8","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray, J. J., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., & Zile, M. R. (2014). PARADIGM-HF Investigators and Comittees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. The New England Journal of Medicine, 371, 993\u20131004.","journal-title":"The New England Journal of Medicine"},{"issue":"6","key":"10041_CR9","first-page":"330","volume":"8","author":"L Fala","year":"2015","unstructured":"Fala, L. (2015). Entresto (sacubitril\/valsartan): First in class angiotension receptor neprilysin inhibitor FDA approved for patients with heart failure. American Health & Drug Benefits, 8(6), 330\u2013334.","journal-title":"American Health & Drug Benefits"},{"issue":"6","key":"10041_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMoa1812851","volume":"380","author":"EJ Velazquez","year":"2019","unstructured":"Velazquez, E. J., Morrow, D. A., DeVore, A. D., Duffy, C. I., Ambrosy, A. P., McCague, K., Rocha, R., & Braunwald, E. (2019). Angiotensin-neprilysin inhibition in acute decompensated heart failure. The New England Journal of Medicine, 380(6), 539\u2013548.","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10041_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.amjcard.2013.09.025","volume":"113","author":"P Thavendiranathan","year":"2014","unstructured":"Thavendiranathan, P., Yingchoncharoen, T., Grant, A., Seicean, S., Landers, S. H., Gorodeski, E. Z., & Marwic, T. H. (2014). Prediction of 30-day heart failure-specific readmission risk by echocardiographic parameters. The American Journal of Cardiology, 113(2), 335\u2013341.","journal-title":"The American Journal of Cardiology"},{"issue":"6","key":"10041_CR12","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.echo.2015.02.007","volume":"28","author":"M Saito","year":"2015","unstructured":"Saito, M., Negishi, K., Eskandari, M., Huynh, Q., Hawson, J., Moore, A., Koneru, S., Foster, S., & Marwick, T. H. (2015). Association of left ventricular strain with 30-day mortality and readmission in patients with heart failure. Journal of the American Society of Echocardiography, 28(6), 652\u2013666.","journal-title":"Journal of the American Society of Echocardiography"},{"issue":"12","key":"10041_CR13","first-page":"1351","volume":"8","author":"M Sengel\u00f8v","year":"2015","unstructured":"Sengel\u00f8v, M., J\u00f8rgensen, P. G., Jensen, J. S., Bruun, N. E., Olsen, F. J., Fritz-Hansen, T., Nochioka, K., & Biering-S\u00f8rensen, T. (2015). Global longitudinal strain is a superior predictor of all-cause mortality in heart failure with reduced ejection fraction. JACC: Cardiovascular Imaging, 8(12), 1351\u20131359.","journal-title":"JACC: Cardiovascular Imaging"},{"issue":"1","key":"10041_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12947-017-0098-3","volume":"15","author":"S Romano","year":"2017","unstructured":"Romano, S., Mansour, I. N., Kansal, M., Gheith, H., Dowdy, Z., Dickens, C. A., Buto-Colletti, C., Chae, J. M., Saleh, H. H., & Stamos, T. D. (2017). Left ventricular global longitudinal strain predicts heart failure readmission in acute decompensated heart failure. Cardiovascular Ultrasound, 15(1), 6.","journal-title":"Cardiovascular Ultrasound"},{"issue":"1","key":"10041_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L., Flachskampf, F. A., Foster, E., Goldstein, S. A., Kuznetsova, T., Lancellotti, P., Muraru, D., Picard, M. H., Rietzschel, E. R., Rudski, L., Spencer, K. T., Tsang, W., & Voigt, J. U. (2015). Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Journal of the American Society of Echocardiography, 28(1), 1\u201339.","journal-title":"Journal of the American Society of Echocardiography"},{"key":"10041_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.echo.2012.10.008","volume":"26","author":"T Yingchoncharoen","year":"2013","unstructured":"Yingchoncharoen, T., Agarwal, S., Popovi\u0107, Z. B., & Marwick, T. H. (2013). Normal ranges of left ventricular strain: A meta-analysis. Journal of the American Society of Echocardiography, 26, 185\u2013191.","journal-title":"Journal of the American Society of Echocardiography"},{"issue":"1","key":"10041_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12933-017-0615-6","volume":"16","author":"A Natali","year":"2017","unstructured":"Natali, A., Nesti, L., Fabiani, I., Calogero, E., & Di Bello, V. (2017). Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanics involved in myocardial disease progression in type 2 diabetes: Rationale and design of the EMPA-HEART trail. Cardiovascular Diabetology, 16(1), 130.","journal-title":"Cardiovascular Diabetology"},{"issue":"6","key":"10041_CR18","first-page":"108","volume":"7","author":"A Almufleh","year":"2017","unstructured":"Almufleh, A., Marbach, J., Chih, S., Standnick, E., Davies, R., Liu, P., & Mielniczuk, L. (2017). Ejection fraction improvement and reverse remodeling achieved with sacubitril\/valsartan in heart failure with reduced ejection fraction patients. American Journal of Cardiovascular Disease, 7(6), 108\u2013113.","journal-title":"American Journal of Cardiovascular Disease"},{"key":"10041_CR19","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.3390\/jcm8122165","volume":"8","author":"G Romano","year":"2019","unstructured":"Romano, G., Vitale, G., Ajello, L., Agnese, V., Bellavia, D., Caccamo, G., Corrado, E., Di Gesaro, G., Falletta, C., La Franca, E., Min\u00e0, C., Storniolo, S. A., Sarullo, F. M., & Clemenza, F. (2019). The effects of sacubitril\/valsartan on clinical, biochemical and echocardiographic parameters in patients with heart failure with reduced ejection fraction: \u201cThe hemodynamic recovery\u201d. Journal of Clinical Medicine, 8, 2165\u20132173.","journal-title":"Journal of Clinical Medicine"},{"key":"10041_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/03007995.2019.1576485","volume":"35","author":"C Parisi","year":"2019","unstructured":"Parisi, C., De Giusti, M., Castello, L., Dito, E., Proietti, F., & Tomai, F. (2019). Sacubitril\/valsartan: Preliminary experience in post acute stabilized patients with reduced ejection fraction heart failure. Current Medical Research and Opinion, 35, 17\u201320.","journal-title":"Current Medical Research and Opinion"},{"key":"10041_CR21","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jacc.2010.05.011","volume":"56","author":"DG Kramer","year":"2010","unstructured":"Kramer, D. G., Trikalinos, T. A., Kent, D. M., Antonopoulos, G. V., Konstam, M. A., & Udelson, J. E. (2010). Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: A meta analytic approach. Journal of the American College of Cardiology, 56, 392\u2013406.","journal-title":"Journal of the American College of Cardiology"},{"key":"10041_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.14740\/cr910","volume":"10","author":"R De Vecchis","year":"2019","unstructured":"De Vecchis, R., Paccone, A., & Di Maio, M. (2019). Sacubitril\/valsartan therapy for 14 months induces a marked improvement of global longitudinal strain in patients with chronic heart failure: A retrospective cohort study. Cardiology Research, 10, 293\u2013302.","journal-title":"Cardiology Research"},{"issue":"1","key":"10041_CR23","first-page":"2","volume":"7","author":"AK Abraham","year":"2017","unstructured":"Abraham, A. K., & Srinivas, T. (2017). New therapeutic regimen in heart failure: A post-marketing study employing speckle tracking echocardiography. Kerala Heart Journal, 7(1), 2.","journal-title":"Kerala Heart Journal"},{"issue":"11","key":"10041_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jama.2019.12843","volume":"322","author":"AS Desai","year":"2019","unstructured":"Desai, A. S., Solomon, S. D., Shah, A. M., Claggett, B. L., Fang, J. C., Izzo, J., McCague, K., Abbas, C. A., Rocha, R., & Mitchell, G. F. (2019). Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: A randomized clinical trail. JAMA, 322(11), 1\u201310.","journal-title":"JAMA"},{"issue":"3","key":"10041_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1161\/CIRCIMAGING.109.910893","volume":"3","author":"J Nahum","year":"2010","unstructured":"Nahum, J., Bensaid, A., Dussault, C., Macron, L., Clemence, D., Bouhemad, B., Monin, J. L., Rande, J. L., Gueret, P., & Lim, P. (2010). Impact of longitudinal myocardial deformation on the prognosis of chronic heart failure patients. Circulation. Cardiovascular Imaging, 3(3), 249\u2013256.","journal-title":"Circulation. Cardiovascular Imaging"},{"issue":"18","key":"10041_CR26","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.jacc.2018.02.064","volume":"71","author":"JJ Park","year":"2018","unstructured":"Park, J. J., Park, J. B., Park, J. H., & Cho, G. Y. (2018). Global longitudinal strain to predict mortality in patients with acute heart failure. Journal of the American College of Cardiology, 71(18), 1947\u20131957.","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10041_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jchf.2019.02.015","volume":"7","author":"C Balmforth","year":"2019","unstructured":"Balmforth, C., Simpson, J., Shen, L., Jhund, P. S., Lefkowitz, M., Rizkala, A. R., Rouleau, J. L., Shi, V., Solomon, S. D., Swedberg, K., Zile, M. R., Packer, M., & McMurray, J. J. V. (2019). Outcomes and effect of treatment according to etiology in HFrEF: An analysis of PARADIGM-HF. JACC Heart Failure, 7(6), 457\u2013465.","journal-title":"JACC Heart Failure"},{"issue":"6","key":"10041_CR28","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ejhf.799","volume":"19","author":"E D'Elia","year":"2017","unstructured":"D'Elia, E., Iacovoni, A., Vaduganathan, M., Lorini, F. L., Perlini, S., & Senni, M. (2017). Neprilysin inhibition in heart failure: Mechanisms and substrates beyond modulating natriuretic peptides. European Journal of Heart Failure, 19(6), 710\u2013717.","journal-title":"European Journal of Heart Failure"},{"issue":"2","key":"10041_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s11897-017-0327-y","volume":"14","author":"E Riddell","year":"2018","unstructured":"Riddell, E., & Vader, J. M. (2018). Potential expanded indications for neprilysin inhibitors. Current Heart Failure Reports, 14(2), 134\u2013145.","journal-title":"Current Heart Failure Reports"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-020-10041-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-020-10041-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-020-10041-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T23:10:10Z","timestamp":1623971410000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-020-10041-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10041"],"URL":"https:\/\/doi.org\/10.1007\/s12265-020-10041-4","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,18]]},"assertion":[{"value":"2 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments. Approval was granted by the Ethics Committee of University Hospital Centre Split, Croatia.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}